
Kanaph Therapeutics
Developer of tumor micro-environment targeting drugs designed to cure solid tumors. The company aims to enhance patient response rates for immuno-oncology drugs by overcoming immune suppression in the...
Valuation
$0
Share Price
N/A
Total Raised
$46.6M
Last Round
N/A